Ivenix vs Medsys AI: Revenue, Funding & Team Size Compared
Last updated
Ivenix generates $300.1K in revenue; Medsys AI generates $330K. Medsys AI and Ivenix are close to the same size by revenue. The table below compares Ivenix and Medsys AI on funding, valuation, customers, team size and headquarters — every figure GetLatka has verified for each company.
| Company |  IvenixThis company |  Medsys AI |
|---|---|---|
| Revenue | $300.1K | $330K |
| Funding raised | $92M | Not disclosed |
| Team size | 6 | 3 |
| Founded | 2007 | Not disclosed |
| HQ | North Andover, United States | Madrid, Spain |
Want the full dataset? GetLatka tracks revenue, funding and team history for thousands of SaaS companies, with charts, growth rates and founder interviews.
Ivenix at a glance
Ivenix generates $300.1K in revenue with 6 employees, headquartered in North Andover, United States.
- Revenue
- $300.1K
- Funding
- $92M
- Team size
- 6
- Founded
- 2007
Developer of a next-generation infusion management platform designed to transform infusion therapy in different care setting. The company's infusion control system manages patient's infusion data and integrates with clinical information…
Medsys AI at a glance
Medsys AI generates $330K in revenue with 3 employees, headquartered in Madrid, Spain.
- Revenue
- $330K
- Team size
- 3
Artificial intelligence to improve the accuracy and efficiency of medical professionals.
Other Ivenix alternatives
Ivenix competes with more than the companies on this page. Browse the full alternative lists to compare revenue, funding and team size across the category.
Ivenix vs Medsys AI: frequently asked questions
Is Ivenix or Medsys AI bigger?
Medsys AI is the bigger company by revenue, at $330K against $300.1K for Ivenix.
How much revenue does Ivenix make?
Ivenix generates $300.1K in annual revenue with a team of 6.
How much revenue does Medsys AI make?
Medsys AI generates $330K in annual revenue with a team of 3.
How much funding has Ivenix raised?
Ivenix has raised $92M in total funding since it was founded in 2007.